Intellia Therapeutics Inc buy Wolfe Research
Start price
21.04.25
/
50%
€6.94
Target price
21.04.26
€18.30
Performance (%)
62.15%
Price
19:57
€11.25
Summary
This prediction is currently active. With a performance of 62.15% the BUY prediction by Wolfe_Research is a big success. This prediction currently runs until 21.04.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 2.928% | 2.928% |
| iShares Core DAX® | -2.116% | -8.178% |
| iShares Nasdaq 100 | -1.132% | 0.908% |
| iShares Nikkei 225® | -0.658% | -6.257% |
| iShares S&P 500 | -1.261% | -1.001% |
Comments by Wolfe_Research for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $21.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat